Status:
COMPLETED
Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men
Lead Sponsor:
AstraZeneca
Conditions:
Healthy Volunteers
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate the safety and tolerability of multiple once daily ascending doses of AZD3199 in healthy men
Eligibility Criteria
Inclusion
- BMI 19-30, weight 60-100 kg
- Non/ex-smokers, Non/ex-nicotine users
Exclusion
- Any clinically significant disease or disorder
- Any clinically relevant abnormal findings at screening examinations
- Use of any prescribed or non-prescribed medication
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2008
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00713271
Start Date
August 1 2008
End Date
November 1 2008
Last Update
April 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Lund, Sweden